Published on 15 Dec 2023 on Benzinga
Pfizer, Inc. PFE shares are trading higher Friday. The stock remains down by more than 11% over the past five days and down by more than 47% year-to-date.
Here's a look at what's going on:
Start tracking your investments with Statfolio
Corporate earnings came to the market’s rescue in the past week, helping to overcome rate fears. ...
We expect the company to post revenue of $13.8 billion and earnings of $0.50 on a per share and a...
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia Friday, the FDA appr...
What's Going On With Pfizer Stock On Thursday?
In this piece, we will take a look at the 13 best ethical companies to invest in 2024. If you wan...
Moderna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London p...
In this article, we discuss the 10 best performing biotech ETFs in 2024. If you want to skip our ...
EU regulators have approved Pfizer (PFE) and AbbVie’s (ABBV) antibiotic product Emblaveo for the...
In this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you wa...
Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a go...